Brimo-Vision 2 mg/ml, Augentropfen (Einzeldosen)

7680673120033 CH-67312 Augentropfen
Brimo-Vision 2 mg/ml, Augentropfen (Einzeldosen)
Brimo-Vision 2 mg/ml, Augentropfen (Einzeldosen)
1 / 2
google

Article details

Package size
60 x 0.35
Selling units
60
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/06/2023
Summary of Product Characteristics
Français
05/06/2023
Patient information leaflet
Allemand
17/02/2022
Patient information leaflet
Français
17/02/2022
Patient information leaflet
Italien
17/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.32 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 25.70
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2021

Authorization holder

OmniVision AG

8212 Neuhausen am Rheinfall

Authorization information

Swissmedic authorization number
67312
Drug name
Brimo-Vision, Augentropfen, Lösung im Einzeldosisbehältnis
Galenic form
AUTLE
ATC Code
S01EA05
Authorization status
Z
Dispensing category
B
First authorization
25/03/2020
Authorization expiration date
31/12/9999
IT Number
11.09.0.
Domain
Human medicine
Field of application
Weitwinkelglaukom, okuläre Hypertension

Package details

Description (FR)
BRIMO-VISION gtt opht 2 mg/ml 60 monodos 0.35 ml
Description (DE)
BRIMO-VISION Gtt Opht 2 mg/ml 60 Monodos 0.35 ml
Market launch
25/03/2020
Narcotic (BTM)
No

Original drug

Alphagan, Augentropfen
GTIN: 7680546050139
CHF 25.85
View original

Other package sizes (2)

None
None None
GTIN: None
Not in V1
BRIMO-VISION gtt opht 2 mg/ml 180 monodos 0.35 ml
180 x 0.35 ML
GTIN: 7680673120040
View